๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Donor site morbidity following vascularized fibular grafting

โœ Scribed by Christine L. Tang; James L. Mahoney; Michael D. McKee; R.R. Richards; J.P. Waddell; Brian Louie; D. Yoo


Book ID
101266960
Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
34 KB
Volume
18
Category
Article
ISSN
0738-1085

No coin nor oath required. For personal study only.

โœฆ Synopsis


We examined donor site morbidity in thirty-nine patients with avascular necrosis of the femoral head treated by curettage and transplantation of a free ipsilateral fibular graft. Utilising our donor site morbidity questionnaire, scar, functional loss, wound healing, complications, and pain were analysed. Subjective complaints and objective findings were evaluated and compared. Subjective complaints were common and included a sense of instability in 42% and a sense of weakness in 37%. However, objective findings were limited. No clinical instability could be elicited and only great toe flexion (29%) and extension (43%) were found to be mildly weak. Only one patient required reoperation for a donor site problem (2%). Eighty-nine percent were pain free at time of follow-up, and 93% felt the scar was good. Range of motion of the knee and ankle of the donor site leg was not different from the nonoperated leg. Donor site morbidity for avascular necrosis of the femoral head is low.


๐Ÿ“œ SIMILAR VOLUMES


Donor site morbidity in free tarsal graf
โœ Igal Leibovitch; Dinesh Selva; Garry Davis; Raf Ghabrial ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 127 KB
A quantitative analysis of donor site mo
โœ James W. Youdas; Michael B. Wood; Thomas D. Cahalan; Dr. Edmund Y. S. Chao ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 835 KB

Eleven patients with free vascularized fibula graft transplants to the upper extremity were studied for donor-side morbidity effects. Based on their surgical follow-up times, the patients were divided into either group 1 (5 +/- 2 months) or group 2 (21 +/- 8 months) to examine the effects of surgica